 |
|
|
|
 |
| JULY 30 ,
2009 | ISSUE NUMBER 109 VOL 6 |
Deals
GSK Signs $120M Deal to Market DMab Overseas
Amgen’s and GSK will partner to market Amgen’s blockbuster osteoporosis treatment DMab in Europe, China, and other overseas countries once it is approved.
Clinical Trials
NHLBI Cans Sildenafil Study After Reports of Severe Pain
Trial participants being treated for pulmonary hypertension suffered sickle cell pain in clinical trial. The cause: the active ingredient in Viagra.
New Media
Pfizer Joins Twitter Fray
The drug giant, last week, started tweeting about corporate initiatives, job openings, and news. Is Pfizer just jumping on the bandwagon, or is Twitter part of the company’s social media strategy? Pharm Exec talks to Pfizer to find out more.
Marketing
Connecting with Customers in Digital Space
Dani Friedland examines what Johnson & Johnson and other pharmaceutical companies are doing to succeed online.
FDA
Hamburg Shifts Boxes at FDA
Typical of new administrations, FDA Commissioner Margaret Hamburg is moving changing staff functions and bringing in new faces, but holding off on major reorganizational changes at the agency.
|
 |
|  Digitas Health announced the opening of two new locations in London and Boston // UCB Pharma Canada appointed Anne de Cassini to general manager // Saatchi & Saatchi Wellness hired Ned Russell as executive vice president, director of client services // ProCom hired Nikhil Patel, PharmD, as senior medical director and Karen Sullivan, as an editor/writer //
Promotions Unlimited won three awards for educational tools serving diabetics and other self-injecting patients in the 16th annual National Health Information Awards // Clinical Supplies Management promoted Don Berg to president and Gerald Finken to CEO // WuXi PharmaTech appointed Chi-Chung Chan, MD, as vice president of pharmacology // Solace Pharmaceuticals appointed David Julius to its scientific advisory board // Sunesis Pharmaceuticals appointed Helen S. Kim to its board of directors //
|
August 12 An Evolving Standard for Success: Proving Product Value Through Comparative Effectiveness Data
Wednesday, August 12, 2009 at 11AM EDT
|
|
July
30–31 CBI’s
4th Clinical Supply Chain Management Conference,
Princeton, NJ
August
11–22 3rd Annual Forum on Tracking State Laws and Aggregate Spend,
Arlington, VA
September
14–15 4th Annual Forum on Educational Grants for the Bio/Pharmaceutical Industry,
Philadelphia, PA
September
21–24 5th
Annual Process Excellence Week for the Service & Transactional
World, Chicago, IL
September
30 Prix Galien 2009 Awards Ceremony, New York, NY
October
5–7 BioNetwork
2009: The 7th Annual Pharmaceutical-Biotech Partnering
Conference, Laguna Niguel, California |
|
|
|
 |
|
 |
|
 |
| Should the Department of Justice end pharma’s tactic of paying off other firms to postpone generic competition? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
